flow semaglutide trial reduces risk for major kidney disease events in patients with type 2 diabetes Inclusion and exclusion criteria for

Small, consistent improvements in multiple areas compound meaningfully over time

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context for how your body responds to GLP-1 and GIP receptor stimulation

Offer for 2 monthly fills through June 30, 2026, then $349 per month for Ozempic 0.25 mg, 0.5 mg, or 1 mg and $499/month for Ozempic 2 mg

Resume normal routine the following day

Intramuscular desferrioxamine in patients with Alzheimer's disease

Persistent side effects sometimes point to a dose that is too aggressive or a genetic variant affecting GLP-1 sensitivity, which PlexusDx can explore through the Precision Peptide Genetic Test